Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Dr. Reddy's Laboratories Limited | Medchal-Malkajgiri, India | Makes it and tests it | Problems found, fixed voluntarilyOct 27, 2023 · 8 inspections |
Recalls
- Dec 15, 2023 · Class II · Dr. Reddy's Laboratories, Inc.
Presence of Foreign Tablets/Capsules: One 0.5 mg Tacrolimus capsule found in a bottle of 1 mg Tacrolimus capsules.
Lots: Lot# C2307275; Exp. January 2026 - Feb 8, 2023 · Class II · Dr. Reddy's Laboratories, Inc.
Presence of Foreign Tablets/Capsules: Presence of one Tacrolimus 1 mg capsule co-mingled in a bottle containing and labeled as Tacrolimus 0.5 mg capsules.
Lots: Lot # C2106445; Exp. 03/2024
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Tacrolimus: every company that makes it
- Form
- capsule, oral
- Strength
- 5 mg
- Approval
- ANDA ANDA090509
- On the market since
- May 14, 2010
- Package NDCs
55111-527-0155111-527-0555111-527-3055111-527-7855111-527-79- Official label
- DailyMed (National Library of Medicine), updated Nov 1, 2023
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?